huberman retatrutide Neuroscientist Andrew discusses retatrutide, a treatment that could help people lose up to a third of their body weight with minimal muscle loss. >> πMore belowπ Gwyneth Paltrow, Huberman discuss the
Description
GLP-1 Addiction Reduction Evidence in Rodents and Primates Randomized controlled trials in mice, rats, and monkeys have shown strong anti-addiction effects from GLP-1RAs

Retatrutide hits the same receptor, so the same concern applies

Read the original article on Eating Well.

Phase 3 data shows up to 71.2 pounds at 68 weeks

Participants were randomized to either continue the medication or switch to a placebo for another 52 weeks
These participants not only maintained their weight but also lost an additional 1.8% of their body weight on average over 13 weeks [1]